The emergency surgical infection management checklist of hospitalized patients with coronavirus disease 2019 (COVID-19) in Zhejiang, China.


Journal

Annals of palliative medicine
ISSN: 2224-5839
Titre abrégé: Ann Palliat Med
Pays: China
ID NLM: 101585484

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 14 01 2021
accepted: 23 03 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 16 4 2021
Statut: ppublish

Résumé

The novel coronavirus disease 2019 (COVID-19) epidemic broke out in 2019, it is highly contagious, and the infection rate among medical staff is high. The management of infection prevention and control during emergency surgery of COVID-19 patients has been outlined and the perioperative infection management checklist for emergency surgery of COVID-19 patients has been summarized and validated. There have been 13 emergency surgeries performed on COVID-19 patients at our hospital during this time. Two cases were cured and discharged, and the others were discharged after improvement and transferred to further rehabilitation, 30-day mortality of the emergency surgical is 0%. Once the emergency surgery protocol in the hospital is successfully established, emergency surgery can be performed as soon as the surgical planning decision is made, and the operating room can be prepared for use at any time. The incidence of surgical site infection (SSI) was largely higher than that of ordinary patients in the same time; however, the successful implementation of emergency surgery for COVID-19 had positive significance in reducing the incidence of death, risk of bleeding, and hypoxia. The current cumulative cure rate of COVID-19 in our hospital is 98%, patient mortality rate is 0%, and the incidence of COVID-19 infection in medical staff is 0%. The emergency surgical infection management checklist is feasible and effective in guiding the preoperative and intraoperative surgical procedures.

Identifiants

pubmed: 33849129
doi: 10.21037/apm-21-430
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3452-3458

Auteurs

Lingmei Ni (L)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Yanan Zhou (Y)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Zuowei Ni (Z)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Yifang Ma (Y)

Department of Operating Room, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Haiting Fen (H)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Fang Wang (F)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Sheng Zhang (S)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Xiaofang Fei (X)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Qunying Pan (Q)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Xinzheng Hong (X)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Tingting Qu (T)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Zifeng Zhong (Z)

Department of Infection Prevention and Control, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Zuobing Chen (Z)

Department of Rehabilitation Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. czb1971@zju.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH